Yuxiang Lin

1.1k citations

81 papers · 686 indexed · h-index 15

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
Oncology
- HER2/EGFR in Cancer Research

Papers in

Cancer Research 26
- Breast Cancer Treatment Studies 15
- Cancer-related molecular mechanisms research 6
Oncology 30
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 5

Co-authors: Fangmeng Fu Chuan Wang Meng Huang Minyan Chen Wenhui Guo Peidong Yang Chuangui Song Xiaobin Chen
Journals: Frontiers in Oncology (6 papers)Oncotarget (4 papers)Breast Cancer Research and Treatment (4 papers)Journal of Translational Medicine (3 papers)Medicine (3 papers)
Partner nations: China United States Sweden

In The Last Decade

Yuxiang Lin

71 papers receiving 683 citations

Peers

Countries citing papers authored by Yuxiang Lin

Since Specialization

Citations

This map shows the geographic impact of Yuxiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Lin more than expected).

Fields of papers citing papers by Yuxiang Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Lin. The network helps show where Yuxiang Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuxiang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuxiang Lin Line = papers co-authored together Yuxiang Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acupotomy for knee osteoarthritis: Literature review and meta-analysis Journal of Back and Musculoskeletal Rehabilitation ·Anqi Di, Danghan Xu, Anxin Zhang, Zhaoxi Liu, Yuxiang Lin, Nanbu Wang, Jun He, Liang Zheng, Fang Fang	2025	0
2	Study on denoising and enhancement of crane bolt images based on UAV acquisition Guodong Chen, Mingtao Guo, Yuxiang Lin, Honglin Mu, Wenlong Yu, Xing Jin, Yanfei Wu, Haining Xiong, Jinxun Lin, Mingwei Huang	2024	0
3	Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony‐stimulating factor following chemotherapy: Triangulation of evidence using population‐based cohort and Mendelian randomization analyses International Journal of Cancer ·Yali Wang, Weifeng Cai, Peng He, Qindong Cai, Jinhua Huang, Liu Shou-gui, Minyan Chen, Lili Chen, Yuxiang Lin, Jialin Hou, Jing Li, Chengbin Fu, Zhonghua Han, Hui Han, Shunguo Lin, Chunsen Xu, Fangmeng Fu, Chuan Wang	2024	0
4	Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China Frontiers in Oncology ·Dongbing Zhao, Xingxing Yu, Hongli Huang, Shuqing Zou, Pingxiu Zhu, Yuxiang Lin, Mengjie Song, Fangmeng Fu, Haomin Yang	2024	1
5	Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study Frontiers in Immunology ·Xiaobin Chen, Qindong Cai, Lin Deng, Minyan Chen, Xu Min, Lili Chen, Yuxiang Lin, Li Yan, Yali Wang, Hanxi Chen, Shunyi Liu, Jinqiao Wu, Xin Tong, Fangmeng Fu, Chuan Wang	2024	3
6	Genetic and lifestyle factors for breast cancer risk assessment in Southeast China Cancer Medicine ·Shuqing Zou, Yuxiang Lin, Xingxing Yu, Mikael Eriksson, Moufeng Lin, Fangmeng Fu, Haomin Yang	2023	2
7	Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis npj Breast Cancer ·Lili Chen, Fan Wu, Xiaobin Chen, Yazhen Chen, Lin Deng, Qindong Cai, Long Wu, Wenhui Guo, Minyan Chen, Yan Li, Wenzhe Zhang, Jin Xuan, Hanxi Chen, Qian Nie, Xiong Wu, Yuxiang Lin, Chuan Wang, Fangmeng Fu	2023	8
8	Tyrosine kinase inhibitors in HER2‐positive breast cancer brain metastases: A systematic review and meta‐analysis Cancer Medicine ·Yushuai Yu, Kaiyan Huang, Yuxiang Lin, Jie Zhang, Chuangui Song	2023	6
9	The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database BMC Geriatrics ·Kaiyan Huang, Jie Zhang, Yushuai Yu, Yuxiang Lin, Chuangui Song	2022	21
10	Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients BMC Cancer ·Yan Li, Lili Chen, Jinxing Lv, Xiaobin Chen, Bangwei Zeng, Minyan Chen, Wenhui Guo, Yuxiang Lin, Liuwen Yu, Jialin Hou, Jing Li, Peng Zhou, Wenzhe Zhang, Shengmei Li, Jin Xuan, Weifeng Cai, Kun Zhang, Yeyuan Huang, Chuan Wang, Fangmeng Fu	2022	1
11	CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1 Journal of Translational Medicine ·Yuxiang Lin, Jie Zhang, Yan Li, Wenhui Guo, Lili Chen, Minyan Chen, Xiaobin Chen, Wenzhe Zhang, Xuan Jin, Meichen Jiang, Xiao Han, Chuan Wang, Chuangui Song, Fangmeng Fu	2022	37
12	Impact of Postoperative Radiotherapy on Survival of Patients With de novo Stage IV Breast Cancer: A Population-Based Study From the SEER Database Frontiers in Oncology ·Jie Zhang, Shiping Luo, Zhaozhen Qiu, Yuxiang Lin, Chuangui Song	2021	3
13	LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer Frontiers in Oncology ·Wenhui Guo, Jingyi Li, Haobo Huang, Fangmeng Fu, Yuxiang Lin, Chuan Wang	2021	4
14	Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database Frontiers in Oncology ·Kaiyan Huang, Jie Zhang, Wenfen Fu, Yuxiang Lin, Chuangui Song	2020	12
15	Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials Breast Cancer Research and Treatment ·Jing Li, Fangmeng Fu, Liuwen Yu, Meng Huang, Yuxiang Lin, Qian Mei, Jinxing Lv, Chuan Wang	2020	26
16	Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer Breast Cancer Research and Treatment ·Yuxiang Lin, Ling Lin, Fangmeng Fu, Chuan Wang, Anqi Hu, Juanjuan Xie, Meichen Jiang, Zhenxin Wang, Lujie Yang, Rongrong Guo, Pengyuan Yang, Huali Shen	2020	12
17	Genetic variants in long noncoding RNA <em>H19 </em>contribute to the risk of breast cancer in a southeast China Han population OncoTargets and Therapy ·Yuxiang Lin, Fangmeng Fu, Yazhen Chen, Wei Qiu, Songping Lin, Peidong Yang, Meng Huang, Chuan Wang	2017	31
18	Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer Scientific Reports ·Lin Qiu, Fangmeng Fu, Meng Huang, Yuxiang Lin, Yazhen chen, Minyan Chen, Chuan Wang	2016	6
19	[The effect of catalase on smoking related laryngeal squamous cell carcinoma]. PubMed ·Yanhong Liu, La C, Wei Jiang, Guopeng Xu, Yuxiang Lin	2015	1
20	Familial Skewed X Chromosome Inactivation in Adrenoleukodystrophy Manifesting Heterozygotes from a Chinese Pedigree PLoS ONE ·Zhihong Wang, Ai-zhen Yan, Yuxiang Lin, Haihua Xie, Chunyan Zhou, Fenghua Lan	2013	20

About Yuxiang Lin

Yuxiang Lin is a scholar working on Cancer Research, Oncology, Otorhinolaryngology, Genetics and Biological Psychiatry, having authored 81 papers that have together received 686 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (5 papers) and Breast Lesions and Carcinomas (5 papers). The work is most often cited by research in Cancer Research (288 citations), Oncology (207 citations), Molecular Biology (321 citations), Health Informatics (6 citations) and Pulmonary and Respiratory Medicine (130 citations). Yuxiang Lin has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Fangmeng Fu, Chuan Wang, Meng Huang, Minyan Chen, Chuan Wang, Wenhui Guo, Peidong Yang, Fangmeng Fu, Chuangui Song and Xiaobin Chen. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Breast Cancer Research and Treatment, Journal of Translational Medicine and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact